DJIA 17,440.59 -127.94 -0.73%
NASDAQ 5,039.78 -48.85 -0.96%
S&P 500 2,067.64 -12.01 -0.58%
market minute promo


company name or ticker
Company Photos
(Click to zoom)

Benzinga's Top #PreMarket Losers

Is Ariad Pharmaceuticals (ARIA) Stock a Solid Choice Right Now? - Tale of the Tape

This ETF Holds Stocks Insiders Want to Own

ARIAD & Angelini Team Up to Commercialize Iclusig in Europe - Analyst Blog

ARIAD & Angelini Team Up to Commercialize Iclusig in Europe - Analyst Blog

Tuesday's #PreMarket Movers: Neuroderm, Microsoft, Medbox, Civeo And More

Health Care Sector Update for 12/30/2014: ARIA, OGXI, NDRM, IDRA

China Biotech Week In Review: Otsuka Buys Rights To ARIAD's Leukemia Drug

China Biotech Week In Review: Otsuka Buys Rights To ARIAD's Leukemia Drug

Tuesday's #PreMarket Movers: NQ Mobile, Cytokinetics, Walgreen And More

Adam Feuerstein's 2014 Biotech Stock Report Card (No Grading on a Curve)

Does George Soros Think Biotech's Bull Run Is Finally Coming to an End?

The Soros Fund Managment sold off a number of biotechs in the third quarter. Do the actions of this closely watched fund signal that the industry's bull run is finally winding down?